Poiré, X., Moser, B. K., Gallagher, R. E., Laumann, K., Bloomfield, C. D., Powell, B. L., . . . Stock, W. (2014). Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): Prognostic significance of FLT3 mutations and complex karyotype. Leuk Lymphoma.
Chicago Style citaatPoiré, Xavier, et al. "Arsenic Trioxide in Front-line Therapy of Acute Promyelocytic Leukemia (C9710): Prognostic Significance of FLT3 Mutations and Complex Karyotype." Leuk Lymphoma 2014.
MLA citatiePoiré, Xavier, et al. "Arsenic Trioxide in Front-line Therapy of Acute Promyelocytic Leukemia (C9710): Prognostic Significance of FLT3 Mutations and Complex Karyotype." Leuk Lymphoma 2014.
Let op: Deze citaties zijn niet altijd 100% accuraat.